The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-98131-4
Abstract: Immune checkpoint blockade, an immunotherapy, has been applied in multiple systemic malignancies and has improved overall survival to a relatively great extent; whether it can be applied in breast cancer remains unknown. We endeavored to… read more here.
Keywords: breast carcinomas; immunotherapy; breast; breast cancer ... See more keywords